News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
162 Results
162 Results
R3 Seminar Recap: RECOVER in Action: Disparities and Environmental Risk Factors in PASC, EHR Insights
During the July 11th RECOVER Research Review (R3) Seminar, presenters discussed the disparities and environmental risk factors in PASC using EHR Insights. This seminar explored racial and ethnic disparities as well as community-level environmental factors in PASC among adults.
R3 Seminar Recap
R3 Seminar Recap: RECOVER in Action: Characterization of PASC Among Adults, Cohort Insights
During the June 13th RECOVER Research Review (R3) Seminar, RECOVER researchers described a symptom-based approach for defining long COVID in adults from a study published in JAMA. This presentation is based upon some early findings from the RECOVER Adult Observational Cohort study.
R3 Seminar Recap
RECOVER Research Q&A: RECOVER “First Look” Adult Cohort Study
Find answers to some of the most frequently asked questions (FAQs) about the first findings from RECOVER's research on Long COVID in adults.
Q&A
Large study provides scientists with deeper insight into Long COVID symptoms
RECOVER researchers have identified the 12 symptoms that are most likely to be experienced by adults with Long COVID.
News Release
Obstructive sleep apnea associated with increased risks for Long COVID
RECOVER researchers examined more than 2.2 million Americans' health data to learn why some people are more likely to develop Long COVID.
News Release
R3 Seminar Recap: RECOVER in Action: PASC in Children and Adolescents, EHR Insights
During the May 9th RECOVER Research Review (R3) Seminar, researchers from PEDSnet presented RECOVER research about PASC in children and adolescents using EHR data. The panelists discussed the clinical features and burden of pediatric PASC and explained how research findings could be used to develop a definition of long COVID in children.
R3 Seminar Recap
R3 Seminar Recap: RECOVER in Action: Status of Clinical Trial Protocols
During the April 25th RECOVER Research Review (R3) Seminar, researchers presented the status of RECOVER clinical trial protocols. Presenters discussed the landscape of Long COVID's clinical trials and the development of RECOVER's upcoming clinical trials.
R3 Seminar Recap
R3 Seminar Recap: Mechanistic Pathways of PASC Session 3: Organ Damage and Reprogramming of Host Tissues and Organs
During the April 11th RECOVER Research Review (R3) Seminar, researchers explored the mechanistic pathways of PASC, focusing on how the virus that causes COVID-19 led to long-term effects. Presenters discussed the molecular basis of Long COVID, including olfactory impairment, plasma proteomics, and the role of T-cell chronotypes in autoimmunity.
R3 Seminar Recap